Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep988 | Thyroid (non-cancer) | ECE2016

Malignancy is associated with microcalcification and AP/T ratio in ultrasonography, but not with Hashimoto’s thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology

Topaloglu Oya , Baser Husniye , Cuhaci Neslihan , Sungu Nuran , Yalcin Abdussamed , Ersoy Reyhan , Cakir Bekir

Introduction: The predictors of malignancy are important for decision of appropriate management in nodules with atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS). Our aim was to determine the ultrasonographical, clinical and biochemical predictors of malignancy in these patients.Methods: A total of 427 patients with Bethesda Category III (AUS/FLUS) thyroid nodules were included in this retrospective study. We d...

ea0041ep998 | Thyroid (non-cancer) | ECE2016

Hemithyroidectomy seems to be a reasonable initial surgical approach for patients with cytologically Bethesda Category III (AUS/FLUS) thyroid nodules

Bilginer Cuneyt , Ozdemir Didem , Topaloglu Oya , Aydin Cevdet , Dumlu Gurkan , Dogan Hayriye , Ersoy Reyhan , Cakir Bekir

Introduction: Atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) termed as Bethesda Category III constitute 15–30% of thyroid cytology. However, the risk of malignancy in this heterogenous category is estimated as 5–15%. The recent studies has been reported the malignancy rate in the wide range of 6–48%. This causes surgical approach variability between different centers. We aimed to evaluate the initial malignancy rate...

ea0041ep1099 | Thyroid cancer | ECE2016

Are there any differences between demographic characteristics, preoperative ultrasonographic findings, and cytological results of patients with thyroid tumors of uncertain malignant potential and papillary thyroid carcinoma of classical and non-encapsulated follicular variants?

Baser Husniye , Topaloglu Oya , Tam Abbas Ali , Alkan Afra , Kilicarslan Aydan , Ersoy Reyhan , Cakir Bekir

Introduction: Thyroid tumors of uncertain malignant potential (TT-UMP) has been accepted as a subgroup of follicular-patterned thyroid tumors for which benignancy or malignancy cannot be assessed exactly. We aimed to evaluate demographic characteristics, ultrasound (US) findings, and cytological results of patients with TT-UMP and compare these findings with the classical variant of papillary thyroid carcinoma (CV-PTC) and non-encapsulated follicular variant of PTC (NEFV-PTC) ...

ea0041ep1108 | Thyroid cancer | ECE2016

Ultrasonographical, clinical and histopathological features of 1264 nodules with papillary thyroid carcinoma and microcarcinoma based on tumor size

Cuhaci Neslihan , Baser Husniye , Topaloglu Oya , Ozdemir Didem , Kilicarslan Aydan , Ersoy Reyhan , Cakir Bekir

Introduction: In recent years, due to the improvements in ultrasonography (US), it has become possible to gain more information about the papillary throid carcinoma (PTC) and papillary tyroid microcarcinoma (PTMC). However, whether PTC and PTMC exhibit the same ultrasonographic features and behave same features is controversial. We aimed to evaluate the patients diagnosed with PTC and PTMC in terms of clinical, ultrasonographical (US) and histopathological features and their r...

ea0037ep65 | Adrenal cortex | ECE2015

Urinary metanephrine levels can be spurious in the diagnosis of patients with phaeochromocytoma: preliminary results from a single centre

Topaloglu Oya , Baser Husniye , Aydin Cevdet , Dirikoc Ahmet , Ersoy Reyhan , Erel Ozcan , Cakir Bekir

Introduction: Phaeochromocytomas (PHEO) are diagnosed with classic findings and symptoms but biochemical confirmation must be made. Either urinary or plasma chatecholamines and metanephrines can be used for biochemical evaluation. Normal values rule out the diagnosis, whereas fourfold increase above the upper limit of normal confirm the diagnosis. But value of borderline or less than fourfold elevations in the diagnosis is not clear. We aimed to determine the urinary fractiona...

ea0037ep1210 | Clinical Cases–Pituitary/Adrenal | ECE2015

A case of pleomorphic adenoma and acromegaly: a coincidence or a pathophysiological association?

Topaloglu Oya , Polat Sefika Burcak , Ozturk Cemaleddin , Bavbek Murat , Muderris Togay , Ersoy Reyhan , Cakir Bekir

Introduction: Acromegaly is a chronic disease caused by excessive secretion of growth hormone (GH), and as a result, of insulin-like growth factor-1 (IGF1). Although controversial, frequency of both benign and malignant neoplasm formation is thought to be increased in acromegalic patients. Pleomorphic adenoma is the most common arising tumour from the parotid salivary gland. Here we report the case of a 33-year-old woman with acromegaly and also who presented with a swelling o...

ea0070ep349 | Pituitary and Neuroendocrinology | ECE2020

Intravenous dexamethasone suppression test in cushing syndrome diagnosis: Three cases

Ince Urcan , Aydin Cevdet , Yildirim Deryol Hilal , Bestepe Nagihan , Topaloglu Oya , Berker Dilek

Introduction: Dexamethasone Suppression Test (DST) is a useful approach in diagnosis and differential diagnosis of Cushing Syndrome (CS) despite its limitations. One of the major limitations is the difficulty to provide standard suppression dose depending on the variability of gastrointestinal absorption. One solution is for this testing serum Dexamethasone levels or test it with intravenous (iv) Dexamethasone In this case, we examined 3 patients to whom we applied intravenous...

ea0022p153 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Heart rate variability in adults with hypopituitarism and severe growth hormone deficiency

Topaloglu Oya , Gokay Ferhat , Berker Dilek , Kahraman Erkan , Topaloglu Serkan , Guler Serdar

Objective: Hypopituitary patients receiving convensional hormone substitution, but without growth hormone (GH) replacement, have an increased mortality from cardiovascular disease. The aim of the present study was to assess the heart rate variability(HRV) in hypopituitary patients with severe GH deficiency.Material and method: Thirty-five patients (20 women, 15 men, aged 23-75 years) with severe GH deficiency, all of 35 patients with low insulin-like gro...

ea0056p186 | Bone ' Osteoporosis | ECE2018

Teriparatide treatment in a patient with atypical femoral fractures associated with long-term bisphosphonate therapy

Bestepe Nagihan , Aydin Cevdet , Evranos Berna , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

Introduction: Bisphosphonates are the most commonly used drugs for the treatment of osteoporosis and have been shown to improve bone mineral density and reduce fractures. However, approximately a decade ago, atypical femoral shaft fractures were found to be a rare complication of bisphosphonate treatment. Atypical Femoral Fractures (AFF) represent fractures located between the lesser trochanter and the supracondylar flare of a femur. An increasing pool of evidence supports the...

ea0056p187 | Bone ' Osteoporosis | ECE2018

Detection of pulmonary metastases with 18F-Fluorocholine PET/CT and treatment of refractory hypercalcemia with denosumab in a patient with long term parathyroid carcinoma

Bestepe Nagihan , Topaloglu Oya , Soydal Cigdem , Yildirim Nilufer , Ersoy Reyhan , Cakir Bekir

Introduction: Parathyroid carcinoma (PC) mediated hypercalcemia is often severe and more resistant to medical treatment. 18F-Fluorocholine PET/CT is a new technique used for determining the localization of parathyroid lesions. Denosumab, novel antiresorbtive agent, has been shown to have a useful role in hypercalcemia treatment. We report a male patient in long-term follow-up of PC who had refractory hypercalcemia due to pulmonary metastases revealed with 18-Fluorocholine PET/...